So who cares, like what does this actually do and why would a pharmaceutical company pay money for it. So for pharmaceutical companies, the bottom line benefit is the following. These data driven computer models increase the probability of getting a pre-clinical drug to market and that's the whole...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login
